NIH-funded research R01 grant

Immune cells in gum disease and type 2 diabetes

Official title: Single-cell RNA-sequencing for functional analysis of monocytes and macrophages in periodontitis

Funded at University of California, San Francisco · NIH-11247071 · Data updated 2026-11-12

They will use single-cell RNA tools to look closely at immune cells in people with gum disease, especially those who also have type 2 diabetes or are Black.

More Periodontitis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startAugust 1, 2024
Project endNovember 30, 2028
Funding year2026
Award (this year)$608,730
NIH project number5R01DE032433-04
Project IDNIH-11247071 on NIH RePORTER

Who could benefit from this research

Could help

Adults with periodontitis, especially those who have type 2 diabetes or identify as Black, who are willing to provide blood and small gum tissue samples and attend clinic visits at UCSF.

Less likely to help

People without periodontitis, children, or those seeking immediate clinical treatment rather than contributing biological samples are unlikely to get direct benefit from this research.

What this research studies

If you join, researchers will collect small gum tissue samples and blood from people with periodontitis, with and without type 2 diabetes, to profile immune cells at the single-cell level. They will focus on monocytes and macrophages to see which cell types and gene programs are linked to worse gum damage and inflammation. The team will compare samples from different racial groups to better understand why Black patients often have more severe disease and will study an epigenetic regulator (JMJD3) that may control immune behavior. The goal is to map immune changes that could point to new targeted anti-inflammatory approaches.

Why it matters

Potential benefit: If successful, this could point to new ways to reduce gum inflammation and tooth loss in people with periodontitis and type 2 diabetes and help tailor therapies for groups at higher risk.

How similar studies have gone: Earlier single-cell work has revealed immune cell differences in gum disease and diabetes, so this project builds on prior findings but remains exploratory in linking cell programs to function and disparities.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Momen Heravi, Fatemeh — University of California, San Francisco
  • Study coordinator: Momen Heravi, Fatemeh

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.